|
1
|
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.
|
Clin Infect Dis
|
1999
|
2.81
|
|
2
|
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease].
|
Arch Bronconeumol
|
2002
|
2.03
|
|
3
|
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
|
JAMA
|
1996
|
1.77
|
|
4
|
Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA.
|
J Hosp Infect
|
1997
|
1.64
|
|
5
|
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.
|
Clin Infect Dis
|
1995
|
1.64
|
|
6
|
[Human papillomavirus vaccines: a new challenge for pediatricians].
|
An Pediatr (Barc)
|
2006
|
1.40
|
|
7
|
[The return of gram-positive bacteria].
|
Enferm Infecc Microbiol Clin
|
1993
|
1.38
|
|
8
|
[Comparative study of pneumococcal bacteremia in patients with and without HIV infection].
|
Rev Clin Esp
|
1993
|
1.36
|
|
9
|
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
|
Antimicrob Agents Chemother
|
2003
|
1.34
|
|
10
|
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease].
|
Aten Primaria
|
2001
|
1.31
|
|
11
|
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
|
Antimicrob Agents Chemother
|
2000
|
1.28
|
|
12
|
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.
|
Antimicrob Agents Chemother
|
1994
|
1.27
|
|
13
|
Specificities of antibodies to native DNA.
|
Scand J Rheumatol Suppl
|
1975
|
1.24
|
|
14
|
The central nervous system and infection by Candida species.
|
Diagn Microbiol Infect Dis
|
2000
|
1.17
|
|
15
|
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.
|
Antimicrob Agents Chemother
|
1999
|
1.12
|
|
16
|
Comparison of epidemiological markers of Salmonella strains isolated from different sources in Spain.
|
J Clin Microbiol
|
1992
|
1.10
|
|
17
|
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999.
|
J Antimicrob Chemother
|
2001
|
1.10
|
|
18
|
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
|
Antimicrob Agents Chemother
|
1993
|
1.06
|
|
19
|
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
|
Eur J Clin Microbiol Infect Dis
|
1992
|
0.97
|
|
20
|
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
|
Clin Microbiol Infect
|
2011
|
0.96
|
|
21
|
Endophthalmitis caused by Listeria monocytogenes.
|
J Clin Microbiol
|
2001
|
0.95
|
|
22
|
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
|
Antimicrob Agents Chemother
|
2004
|
0.95
|
|
23
|
In vitro activity of tigecycline against Bacteroides species.
|
J Antimicrob Chemother
|
2005
|
0.93
|
|
24
|
[Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
|
An Esp Pediatr
|
2002
|
0.92
|
|
25
|
Impact of the BACTEC NR system in detecting Candida fungemia.
|
J Clin Microbiol
|
1990
|
0.91
|
|
26
|
Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.
|
Antimicrob Agents Chemother
|
1992
|
0.91
|
|
27
|
Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies.
|
Infect Control Hosp Epidemiol
|
1994
|
0.91
|
|
28
|
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
|
Antimicrob Agents Chemother
|
1990
|
0.89
|
|
29
|
[Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008].
|
An Pediatr (Barc)
|
2008
|
0.88
|
|
30
|
In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
|
Rev Esp Quimioter
|
2011
|
0.88
|
|
31
|
Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
|
Diagn Microbiol Infect Dis
|
1999
|
0.86
|
|
32
|
[Bacteremia by Staphylococcus aureus: analysis of 311 episodes].
|
Enferm Infecc Microbiol Clin
|
1999
|
0.85
|
|
33
|
Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome.
|
J Autoimmun
|
1995
|
0.84
|
|
34
|
Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.
|
J Antimicrob Chemother
|
2001
|
0.83
|
|
35
|
Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection.
|
Arch Neurol
|
1996
|
0.83
|
|
36
|
Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci.
|
J Antimicrob Chemother
|
2001
|
0.83
|
|
37
|
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
|
J Antimicrob Chemother
|
1999
|
0.81
|
|
38
|
Peritonitis caused by Haemophilus parainfluenzae in a patient undergoing continuous ambulatory peritoneal dialysis.
|
J Clin Microbiol
|
1999
|
0.81
|
|
39
|
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2].
|
Enferm Infecc Microbiol Clin
|
1992
|
0.81
|
|
40
|
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
|
Eur J Clin Microbiol Infect Dis
|
2010
|
0.80
|
|
41
|
Penicillin tolerance of group A streptococci.
|
Eur J Clin Microbiol Infect Dis
|
1989
|
0.80
|
|
42
|
[Community-acquired respiratory infections].
|
Enferm Infecc Microbiol Clin
|
1997
|
0.80
|
|
43
|
[Sensitivity to antimicrobials of group A Streptococcus].
|
Enferm Infecc Microbiol Clin
|
1989
|
0.79
|
|
44
|
[Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR)].
|
Enferm Infecc Microbiol Clin
|
2000
|
0.79
|
|
45
|
[Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2007].
|
An Pediatr (Barc)
|
2007
|
0.79
|
|
46
|
Prevalence of herpesvirus DNA in MS patients and healthy blood donors.
|
Acta Neurol Scand
|
2002
|
0.79
|
|
47
|
A rare cause of pericarditis.
|
Clin Microbiol Infect
|
2003
|
0.79
|
|
48
|
[Diarrhea associated with Helicobacter pullorum in a child].
|
Rev Esp Quimioter
|
2011
|
0.78
|
|
49
|
[Prevalence and treatment of Gram-positive infections in internal medicine departments of Spanish hospitals: IGP Study].
|
Rev Esp Quimioter
|
2003
|
0.78
|
|
50
|
DNA release and appearance of antinuclear antibodies in chronic hemodialysis patients.
|
Nephron
|
1982
|
0.78
|
|
51
|
Outbreak of TEM-24-producing Enterobacter aerogenes in a Spanish hospital.
|
Microb Drug Resist
|
2003
|
0.77
|
|
52
|
In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain.
|
Eur J Clin Microbiol Infect Dis
|
2011
|
0.77
|
|
53
|
[Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations].
|
Rev Esp Quimioter
|
2002
|
0.77
|
|
54
|
[Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
|
Rev Esp Quimioter
|
1999
|
0.77
|
|
55
|
In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates.
|
J Antimicrob Chemother
|
2005
|
0.77
|
|
56
|
[Bacteremic infection due to Nocardia otitidiscaviarum: case report and review].
|
An Med Interna
|
2005
|
0.77
|
|
57
|
[National consensus on acute otitis media (OMA)].
|
An Pediatr (Barc)
|
2007
|
0.76
|
|
58
|
Hepatitis G virus infection in Spanish patients with hepatocellular carcinoma.
|
Liver
|
1998
|
0.75
|
|
59
|
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
|
Antimicrob Agents Chemother
|
2001
|
0.75
|
|
60
|
[Evaluation of an agglutination method of latex particles sensitized for the detection of vaginal candidiasis].
|
Med Clin (Barc)
|
1990
|
0.75
|
|
61
|
[Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
|
Rev Clin Esp
|
1999
|
0.75
|
|
62
|
[Intrinsic resistance of Haemophilus influenzae to beta-lactam drugs].
|
Med Clin (Barc)
|
1998
|
0.75
|
|
63
|
[Methicillin-resistant Staphylococcus aureus: role of the microbiologist].
|
Enferm Infecc Microbiol Clin
|
1992
|
0.75
|
|
64
|
[Carrier state of groups A, B, C, and D beta-hemolytic streptococci].
|
Enferm Infecc Microbiol Clin
|
1994
|
0.75
|
|
65
|
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
|
Rev Esp Quimioter
|
2001
|
0.75
|
|
66
|
[Beta-lactamase producing bacteria in the pharyngeal flora of patients with acute pharyngitis].
|
Enferm Infecc Microbiol Clin
|
1995
|
0.75
|
|
67
|
[Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
|
Enferm Infecc Microbiol Clin
|
1999
|
0.75
|
|
68
|
[Antinuclear antibodies].
|
Sangre (Barc)
|
1977
|
0.75
|
|
69
|
[Management in clinical microbiology].
|
Enferm Infecc Microbiol Clin
|
1999
|
0.75
|
|
70
|
[Criteria for including vaccines in the immunization schedule of the Spanish Association of Pediatrics].
|
An Pediatr (Barc)
|
2008
|
0.75
|
|
71
|
[Bacteremia caused by Streptococcus pneumoniae and HIV infection].
|
Enferm Infecc Microbiol Clin
|
1991
|
0.75
|
|
72
|
[Impact of tuberculosis in Madrid: analysis of clinical and epidemiological parameters in a General Hospital during 2002].
|
Rev Clin Esp
|
2006
|
0.75
|
|
73
|
[Recent advances in the hormonal treatment of sterility (author's transl)].
|
Reproduccion
|
1976
|
0.75
|
|
74
|
[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].
|
Rev Esp Quimioter
|
2017
|
0.75
|
|
75
|
[How to stimulate the placental function (author's transl)].
|
Reproduccion
|
1977
|
0.75
|
|
76
|
[Antimicrobial treatment: some considerations regarding its economic evaluation].
|
Enferm Infecc Microbiol Clin
|
1996
|
0.75
|
|
77
|
[National consensus on acute otitis media].
|
Acta Otorrinolaringol Esp
|
2007
|
0.75
|
|
78
|
[Post-pill amenorrhea and anovulation (author's transl)].
|
Reproduccion
|
1977
|
0.75
|
|
79
|
[Bacteremic pneumonia caused by Rhodococcus equi and HIV infection. Report of a new case and review of the literature].
|
Enferm Infecc Microbiol Clin
|
1991
|
0.75
|
|
80
|
[How to stimulate ovulation?].
|
Tokoginecol Pract
|
1977
|
0.75
|
|
81
|
[Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease].
|
Rev Esp Quimioter
|
2001
|
0.75
|
|
82
|
[The Internet].
|
Enferm Infecc Microbiol Clin
|
2001
|
0.75
|
|
83
|
[Sternal osteomyelitis and mediastinitis due to Fusobacterium necrophorum].
|
Rev Esp Quimioter
|
2014
|
0.75
|
|
84
|
[Detection of human papillomavirus DNA in women with and without signs of infection].
|
Enferm Infecc Microbiol Clin
|
1991
|
0.75
|
|
85
|
[Evidence-based medicine and infectious diseases].
|
Enferm Infecc Microbiol Clin
|
1999
|
0.75
|
|
86
|
Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
|
Rev Esp Quimioter
|
2006
|
0.75
|
|
87
|
[Patterns of susceptibility in group A streptococci].
|
Enferm Infecc Microbiol Clin
|
1994
|
0.75
|
|
88
|
[Out-sourcing clinical microbiology?].
|
Enferm Infecc Microbiol Clin
|
2000
|
0.75
|
|
89
|
[Carbapenem resistance determined by metalloenzymes in clinical isolates of Pseudomonas aeruginosa].
|
Rev Esp Quimioter
|
2004
|
0.75
|
|
90
|
In vitro selections of resistant strains by quinolones.
|
J Chemother
|
1989
|
0.75
|
|
91
|
[Why are pediatric empyemas on the increase in Spain?].
|
An Pediatr (Barc)
|
2008
|
0.75
|
|
92
|
[Vaccination schedule of the Spanish association of pediatrics: recommendations 2009].
|
An Pediatr (Barc)
|
2008
|
0.75
|
|
93
|
[The future development of vaccines].
|
Rev Esp Quimioter
|
2007
|
0.75
|
|
94
|
[Microbial drug resistance and the presence of plasmids in Salmonella strains isolated from different sources].
|
Enferm Infecc Microbiol Clin
|
1994
|
0.75
|
|
95
|
[Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures].
|
Rev Esp Quimioter
|
2001
|
0.75
|
|
96
|
Evaluation of four methods for the detection of streptococcal group A antigen directly from throat swabs.
|
Microbiologia
|
1988
|
0.75
|
|
97
|
[Antibiotic-sensitivity of hospital gram negative bacteria in vitro].
|
Med Trop (Madr)
|
1975
|
0.75
|
|
98
|
[Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease].
|
Arch Bronconeumol
|
2003
|
0.75
|
|
99
|
[In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
|
Rev Esp Quimioter
|
2008
|
0.75
|
|
100
|
[Should an antibiotic be used to treat a patient with arteriosclerosis?].
|
Enferm Infecc Microbiol Clin
|
1998
|
0.75
|
|
101
|
[Actinomycosis].
|
Med Clin (Barc)
|
1999
|
0.75
|